493800 Sigma-AldrichPARP Inhibitor VI, NU1025 - CAS 90417-38-2 - Calbiochem
The PARP Inhibitor VI, NU1025, also referenced under CAS 90417-38-2, controls the biological activity of PARP. This small molecule/inhibitor is primarily used for Cell Structure applications.
More>> The PARP Inhibitor VI, NU1025, also referenced under CAS 90417-38-2, controls the biological activity of PARP. This small molecule/inhibitor is primarily used for Cell Structure applications. Less<<MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
同义词: 8-Hydroxy-2-methylquinazoline-4-one
Recommended Products
概述
Replacement Information |
---|
重要规格表
CAS # | Empirical Formula |
---|---|
90417-38-2 | C₉H₈N₂O₂ |
价格及供货情况
产品目录编号 | 库存情况 | 包装 | 数量 / 包装 | 价格 | 数量 | |
---|---|---|---|---|---|---|
493800-5MGCN |
|
塑胶安瓿;塑胶针药瓶 | 5 mg |
|
— |
Product Information | |
---|---|
CAS number | 90417-38-2 |
ATP Competitive | N |
Form | Off-white solid |
Hill Formula | C₉H₈N₂O₂ |
Chemical formula | C₉H₈N₂O₂ |
Reversible | N |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | PARP |
Primary Target IC<sub>50</sub> | 0.4 µM against poly(ADP-ribose) polymerase (PARP) |
Purity | ≥98% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | N |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
产品目录编号 | GTIN |
493800-5MGCN | 04055977272826 |
Documentation
PARP Inhibitor VI, NU1025 - CAS 90417-38-2 - Calbiochem MSDS
职位 |
---|
PARP Inhibitor VI, NU1025 - CAS 90417-38-2 - Calbiochem 分析证书
标题 | 批号 |
---|---|
493800 |
参考
参考信息概述 |
---|
Delaney, C.A., et al. 2000. Clin. Cancer Res. 6, 2860. Boulton, S., et al. 1999. Carcinogenesis 20, 199. Bowman, K.J., et al. 1998. Br. J. Cancer 78, 1269. Griffin, R.J., et al. 1998. J. Med. Chem. 41, 5247. Griffin, R.J., et al. 1996. Pharm. Sci. 2, 43. Boulton, S., et al. 1995. Br. J. Cancer 72, 849. Griffin, R.J., et al. 1995. Anticancer Drug Res. 10, 507. |